Showing 181 - 200 results of 30,161 for search '"T cells"', query time: 0.10s Refine Results
  1. 181
  2. 182

    Effect of mesenchymal stem cells on animal semen during storage by E. Yu. Zakirova, A. G. Malanyeva, A. M. Aimaletdinov

    Published 2023-12-01
    Subjects: “…mesenchymal stem cells (mscs)…”
    Get full text
    Article
  3. 183
  4. 184
  5. 185
  6. 186
  7. 187
  8. 188
  9. 189

    OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration by Shuzhang Wei, Yin Chen, Xiaokai Shi, Li Zuo, Lifeng Zhang

    Published 2023-01-01
    “…Currently, the role of oncostatin M (OSM) in clear cell renal cell carcinoma (ccRCC) has not been investigated. …”
    Get full text
    Article
  10. 190

    Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration by Shumei Man, Eroboghene E. Ubogu, Katherine A. Williams, Barbara Tucky, Melissa K. Callahan, Richard M. Ransohoff

    Published 2008-01-01
    “…Endothelial cells that functionally express blood brain barrier (BBB) properties are useful surrogates for studying leukocyte-endothelial cell interactions at the BBB. …”
    Get full text
    Article
  11. 191

    Altered Ca2+-Homeostasis of Cisplatin-Treated and Low Level Resistant Non-Small-Cell and Small-Cell Lung Cancer Cells by Kathrin Schrödl, Hamza Oelmez, Martin Edelmann, Rudolf Maria Huber, Albrecht Bergner

    Published 2009-01-01
    “…We aimed at investigating if treatment with cisplatin alters the intracellular Ca2+-homeostasis of lung cancer cells and how this may be related to cisplatin resistance.…”
    Get full text
    Article
  12. 192
  13. 193
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200

    Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes by Yan-Hua Wang, Shotaro Hagiwara, Hiroshi Kazama, Yuki Iizuka, Norina Tanaka, Junji Tanaka

    Published 2024-01-01
    “…Elotuzumab (Elo) is an immune-stimulatory antibody that targets the signaling lymphocytic activation molecule family 7 (SLAMF7) expressed on the surface of MM and NK cells. We confirmed that Elo strongly promoted NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) against SLAMF7-positive MM cells in a CD16-dependent NK cell line, and also activated expanded NK cells derived from peripheral blood mononuclear cells of healthy donors and patients with MM in the present study. …”
    Get full text
    Article